This study focused on evaluating the degradation potential of CTSB on amyloid fibrils with varying clustering tendencies, associated with Alzheimer’s and Parkinson’s diseases, hemodialysis, and lysozyme amyloidosis. The gene discussed is LYZ; the disease is amyloidosis.